Table 4 Newly diagnosed hypertensive patients before and after the pandemic outbreak

BP measurement during first 1.5 years of disease

 BP measured, n(%)

1274(63.0)

421(87.0)

 < 0.0001^b

 number of BP measurements, µ

2.3

2.7

0.089

 BP measured at least 3 times, n(%)

698(34.5)

203(41.9)

0.048^b

 ABPM, n(%)

255(12.6)

90(18.6)

0.013^b

 Basis diagnostic, n(%)

143(7.1)

53(11.0)

0.094^b

 Health Check-up, n(%)

534(35.3)

163(38.6)

0.100^b

Therapy during sample period

 No medical therapy, n(%)

651(32.2)

75(15.5)

 < 0.0001^b

 Mono-therapy, n(%)

458(22.6)

131(27.1)

0.86^b

 Combination-therapy, n(%)

914(45.2)

277(57.2)

 < 0.0001^b

 Number of different drugs, µ

4.3

5.4

0.0012

 Number of different APIs, µ

1.7

2.2

 < 0.0001

 Number of different ATCs, µ

1.4

1.8

 < 0.0001

BP measures at the beginning of disease

 Systolic, µ/N

140.1/931

145.4/319

0.0024

 Diastolic, µ/N

82.0/932

86.0/319

 < 0.0001

  > 140/90 mmHg, n/N(%)

239/931(25.7)

123/319(38.6)

0.0003^b

   < 140/90 mmHg, n/N(%)

387/931(41.6)

102/319(32.0)

0.054^b

BP measures after one year of diagnosis

 Systolic, µ/N

137.1/722

140.5/165

0.86

 Diastolic, µ/N

80.4/722

82.8/165

0.11

 > 140/90 mmHg, n/N(%)

138/721(19.1)

35/165(21.2)

 > 0.999^b

   < 140/90 mmHg, n/N(%)

347/721(48.1)

75/165(45.5)

 > 0.999^b

BP measures differences

 Systolic (Δ), µ/N

0.6/465

2.2/100

 > 0.999

 Diastolic (Δ), µ/N

0.0/465

0.7/100

 > 0.999